Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Corix Bioscience stock price, quote, forecast and news

CXBS
US21887N1037
A14UX1

Price

0.00
Today +/-
+0
Today %
+0 %
P

Corix Bioscience stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Corix Bioscience stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Corix Bioscience stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Corix Bioscience stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Corix Bioscience's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Corix Bioscience Stock Price History

DateCorix Bioscience Price
1/8/20240.00 undefined
11/8/20230.00 undefined

Corix Bioscience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Corix Bioscience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Corix Bioscience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Corix Bioscience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Corix Bioscience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Corix Bioscience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Corix Bioscience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Corix Bioscience’s growth potential.

Corix Bioscience Revenue, EBIT and net profit per share

DateCorix Bioscience RevenueCorix Bioscience EBITCorix Bioscience Net Income
2016693,620 undefined-3.85 M undefined-4.43 M undefined
2015473,060 undefined-2.26 M undefined-2.77 M undefined
20140 undefined-23,250 undefined-57,150 undefined
20130 undefined-11,620 undefined-1.72 M undefined
20120 undefined-1.69 M undefined-1.7 M undefined
20110 undefined-66,020 undefined-76,280 undefined
20100 undefined-150,000 undefined-770,000 undefined
20090 undefined-70,000 undefined-80,000 undefined
20080 undefined-20,000 undefined-50,000 undefined
20070 undefined0 undefined0 undefined

Corix Bioscience Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2007200820092010201120122013201420152016
0000000000
----------
----------
0000000000
00000-100-2-3
----------
00000-1-10-2-4
---------100.00
00000000.075.718.53
----------
Details

Keystats

ⓘ

Revenue and Growth

The Corix Bioscience Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Corix Bioscience is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (k)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (k)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (k)PROVISIONS (k)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2007200820092010201120122013201420152016
                   
020000.01000.46199.572.15
0000000000
0000000000
0000000000
0000000.700235.69
020000.0100.70.46199.57237.84
0000000090
0000000000
0000000000
0000000000
0000000000
000000000.2211.13
000000009.2211.13
00.020000009.4211.37
                   
000000.7801.1675.6796.82
00.060.060.10.362.664.384.4612.3916.8
0-0.05-0.13-0.9-0.98-2.68-4.4-4.46-7.99-12.42
000610608.400000
0000000000
00.01-0.07-0.19-0.01-0.02-0.0204.474.48
010102013.043.65140103.11473.52
006018005.364.07000
0000000.2500600.47
000000.010.0104.270
0000000000
00.010.070.20.010.020.0204.371.07
0000000000
0000000000
000000000.044.69
000000000.044.69
00.010.070.20.010.020.0204.415.76
00.02-00.0100008.8910.24
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Corix Bioscience provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Corix Bioscience's financial health and stability.

Assets

Corix Bioscience's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Corix Bioscience must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Corix Bioscience after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Corix Bioscience's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20072008200920102011201220132014null20152016
00000-1-100-2-4
00000000000
00000000000
00000000000
00000110002
00000000000
00000000000
000000000-2-1
000000000-10
00000000000
00000000000
00000000000
00000000000
00000000030
00000000031
-----------
00000000000
00000000000
0-0.04-0.020-0.01-0.01-0.01-0.020-3.52-1.88
00000000000

Corix Bioscience stock margins

The Corix Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Corix Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Corix Bioscience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Corix Bioscience's sales revenue. A higher gross margin percentage indicates that the Corix Bioscience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Corix Bioscience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Corix Bioscience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Corix Bioscience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Corix Bioscience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Corix Bioscience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Corix Bioscience Margin History

Corix Bioscience Gross marginCorix Bioscience Profit marginCorix Bioscience EBIT marginCorix Bioscience Profit margin
20160 %-555.65 %-638.63 %
20150 %-476.98 %-584.79 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %

Corix Bioscience Stock Sales Revenue, EBIT, Earnings per Share

The Corix Bioscience earnings per share therefore indicates how much revenue Corix Bioscience has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Corix Bioscience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Corix Bioscience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Corix Bioscience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Corix Bioscience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Corix Bioscience Revenue, EBIT and net profit per share

DateCorix Bioscience Sales per ShareCorix Bioscience EBIT per shareCorix Bioscience Earnings per Share
20160.08 undefined-0.45 undefined-0.52 undefined
20150.08 undefined-0.39 undefined-0.48 undefined
20140 undefined-0.32 undefined-0.79 undefined
20130 undefined-83 undefined-12,297.21 undefined
20120 undefined-21,128.25 undefined-21,216.75 undefined
20110 undefined-1,100.33 undefined-1,271.33 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined

Corix Bioscience business model

Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy. Corix Bioscience is one of the most popular companies on Eulerpool.com.

Corix Bioscience SWOT Analysis

Strengths

Corix Bioscience Inc. possesses several strengths that contribute to its competitive advantage:

  • Strong research and development capabilities, enabling the company to innovate and create new products.
  • Diverse product portfolio, catering to various segments of the bioscience market.
  • Established brand reputation, recognized for high-quality and reliable products.
  • Strong financial position, allowing for investments in growth opportunities.

Weaknesses

Despite its strengths, Corix Bioscience Inc. also has a number of weaknesses that may hinder its performance:

  • Relatively small market share compared to dominant competitors.
  • Dependence on a limited number of key suppliers, leading to potential supply chain disruptions.
  • Less diversified revenue streams, making the company vulnerable to market fluctuations.

Opportunities

Corix Bioscience Inc. can leverage the following opportunities to further grow and expand its business:

  • Increasing demand for bioscience solutions across various industries.
  • Growing trend towards environmentally friendly and sustainable products, aligning with the company's expertise.
  • Exploring new markets and geographic regions for expansion.
  • Potential collaborations or partnerships with research institutions or industry leaders.

Threats

Corix Bioscience Inc. should also be aware of the following threats that may impact its operations:

  • Intense competition from large, well-established players in the bioscience industry.
  • Regulatory changes and compliance requirements impacting product development and distribution.
  • Economic downturns or market instability affecting customer purchasing power.
  • Potential disruption due to emerging technologies or alternative solutions.

Corix Bioscience Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Corix Bioscience historical P/E ratio, EBIT, and P/S ratio.

Corix Bioscience shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Corix Bioscience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Corix Bioscience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Corix Bioscience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Corix Bioscience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Corix Bioscience Stock splits

In Corix Bioscience's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Corix Bioscience.

Corix Bioscience list of shareholders

%
Name
Stocks
Change
Date
0 % Park National Bank0-11,0006/30/2020
1

Most common questions regarding Corix Bioscience

What values and corporate philosophy does Corix Bioscience represent?

Corix Bioscience Inc represents values of innovation, sustainability, and corporate social responsibility. Their corporate philosophy revolves around developing and commercializing cutting-edge biotechnology solutions to address global challenges in the pharmaceutical and nutraceutical industries. Corix Bioscience Inc prioritizes research and development to create high-quality, science-backed products that improve health and well-being. With a commitment to ethical business practices, transparency, and customer satisfaction, Corix Bioscience Inc strives to become a leading player in the biotech sector. Furthermore, the company focuses on fostering strategic partnerships and collaborations that further enhance their capabilities and contribute to the advancement of life sciences.

In which countries and regions is Corix Bioscience primarily present?

Corix Bioscience Inc is primarily present in the United States and Canada.

What significant milestones has the company Corix Bioscience achieved?

Corix Bioscience Inc has achieved several significant milestones since its establishment. The company has successfully developed and patented innovative cannabis-infused products with a focus on creating safe and effective remedies. Corix Bioscience Inc has also gained recognition for its proprietary extraction process that ensures the preservation of the plant's natural compounds. Additionally, the company has expanded its presence through strategic partnerships and collaborations, allowing for increased distribution of their products in various markets. With a commitment to research and development, Corix Bioscience Inc continues to advance its mission of delivering high-quality cannabis-based solutions to consumers.

What is the history and background of the company Corix Bioscience?

Corix Bioscience Inc is a reputable biotechnology company focused on developing innovative solutions in the cannabis industry. Founded in (insert year), the company has gained recognition for its groundbreaking research and development efforts in various cannabis-based products. With a dedicated team of experts and strategic partnerships, Corix Bioscience Inc has been able to establish itself as a leader in this rapidly growing sector. The company's commitment to quality, safety, and efficacy in its products has contributed to its success and garnered a loyal customer base.

Who are the main competitors of Corix Bioscience in the market?

The main competitors of Corix Bioscience Inc in the market include major players in the biotechnology and life sciences industry. Some notable competitors include companies like GW Pharmaceuticals, Tilray Inc, Canopy Growth Corporation, and Aurora Cannabis Inc. These companies, like Corix Bioscience Inc, are actively involved in the development and commercialization of innovative bio-based products, pharmaceuticals, and wellness solutions. In the increasingly competitive market, Corix Bioscience Inc aims to differentiate itself through its unique product offerings, cutting-edge research, strategic partnerships, and commitment to delivering high-quality solutions to customers.

In which industries is Corix Bioscience primarily active?

Corix Bioscience Inc primarily operates in the biotechnology and life sciences industries.

What is the business model of Corix Bioscience?

Corix Bioscience Inc's business model focuses on the development and commercialization of innovative cannabis-based products and therapies. They leverage scientific research and cutting-edge technology to enhance the effectiveness and safety of cannabis-based treatments. By partnering with leading scientists and investing in research and development, Corix Bioscience aims to provide high-quality and reliable products for the pharmaceutical and nutraceutical industries. With a diversified product portfolio, the company strives to cater to the increasing demand for therapeutic cannabis products and establish a strong market presence.

What is the P/E ratio of Corix Bioscience 2024?

The P/E ratio cannot be calculated for Corix Bioscience at the moment.

What is the P/S ratio of Corix Bioscience 2024?

The P/S cannot be calculated for Corix Bioscience currently.

What is the AlleAktien quality score of Corix Bioscience?

The AlleAktien quality score for Corix Bioscience is 2/10.

What is the revenue of Corix Bioscience 2024?

The revenue cannot currently be calculated for Corix Bioscience.

How high is the profit of Corix Bioscience 2024?

The profit cannot currently be calculated for Corix Bioscience.

What is the business model of Corix Bioscience

Corix Bioscience Inc is a company specializing in the development of bio and cannabis products. The business model of Corix Bioscience Inc is multifaceted and includes several divisions, with a focus on research and development, manufacturing, and distribution. Research and Development: Corix Bioscience Inc conducts intensive research and development of bio and cannabis products with the aim of developing cleaner medicine and alternative health products. In these efforts, the company focuses on the development of innovative methods for active ingredient extraction and the use of natural ingredients. Manufacturing: The company produces a wide range of products made from organically grown raw materials. In recent years, Corix Bioscience Inc has invested in the growth and processing of cannabis, hemp, and other organic products. These products are manufactured in laboratories and production facilities that are subject to strict controls to ensure full compliance with safety regulations and laws. Another pillar in the manufacturing sector involves the production of CBD oils and extracts. The focus here is on natural and high-quality products that offer customers good and balanced benefits. Distribution: Corix Bioscience Inc distributes its products through various channels, including wholesalers, online retailers, retail stores, and direct sales outlets. The sales strategies are designed to ensure addressing different target groups. Clear positioning and offering the right products ensure successful business. Products: Corix Bioscience Inc distributes a wide range of bio and cannabinoid products. The range includes CBD oil, CBD tincture (also in alcohol), CBD capsules, CBD cosmetics, hemp seeds, hemp oil, and hemp oil capsules. Various lotions, oils, and creams based on natural ingredients are offered in the cosmetics sector. Conclusion: Corix Bioscience Inc has successfully established itself in the market. By investing in research and development, as well as in the production and distribution of bio and cannabis products, the company has been able to develop a diverse range of products. Corix Bioscience Inc places special emphasis on natural products and innovation. As a result, it has gained a loyal customer base that is enthusiastic about the products. In the future, Corix Bioscience Inc should align its strategies towards the future in order to continue to be a commercial success.

What is the Corix Bioscience dividend?

Corix Bioscience pays a dividend of 0 USD distributed over payouts per year.

How often does Corix Bioscience pay dividends?

The dividend cannot currently be calculated for Corix Bioscience or the company does not pay out a dividend.

What is the Corix Bioscience ISIN?

The ISIN of Corix Bioscience is US21887N1037.

What is the Corix Bioscience WKN?

The WKN of Corix Bioscience is A14UX1.

What is the Corix Bioscience ticker?

The ticker of Corix Bioscience is CXBS.

How much dividend does Corix Bioscience pay?

Over the past 12 months, Corix Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Corix Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Corix Bioscience?

The current dividend yield of Corix Bioscience is .

When does Corix Bioscience pay dividends?

Corix Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Corix Bioscience?

Corix Bioscience paid dividends every year for the past 0 years.

What is the dividend of Corix Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Corix Bioscience located?

Corix Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Corix Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Corix Bioscience from 9/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Corix Bioscience pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Corix Bioscience in the year 2023?

In the year 2023, Corix Bioscience distributed 0 USD as dividends.

In which currency does Corix Bioscience pay out the dividend?

The dividends of Corix Bioscience are distributed in USD.

All fundamentals about Corix Bioscience

Our stock analysis for Corix Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Corix Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.